KIRKMAN ROBERT L 4
4 · Oncothyreon Inc. · Filed Dec 4, 2009
Insider Transaction Report
Form 4
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2009-12-03+200,000→ 200,000 totalExercise: $4.71Exp: 2017-12-03→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on December 3, 2010.